A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Trial · NCT00557856
Participant flow63
How many started, completed or left each group, period by period.
21 to 40 of 63
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part 1: Dose Escalation Phase | COMPLETED | PF-03446962 2 mg/kg : Part 1 | 0 | |
| Part 1: Dose Escalation Phase | COMPLETED | PF-03446962 3 mg/kg: Part 1 | 0 | |
| Part 1: Dose Escalation Phase | COMPLETED | PF-03446962 4.5 mg/kg: Part 1 | 0 | |
| Part 1: Dose Escalation Phase | COMPLETED | PF-03446962 6.75 mg/kg: Part 1 | 0 | |
| Part 1: Dose Escalation Phase | COMPLETED | PF-03446962 10 mg/kg: Part 1 | 0 | |
| Part 1: Dose Escalation Phase | COMPLETED | PF-03446962 15 mg/kg: Part 1 | 0 | |
| Part 1: Dose Escalation Phase | COMPLETED | PF-03446962 7 mg/kg: Part 2 | 0 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 0.5 mg/kg: Part 1 | 7 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 1 mg/kg: Part 1 | 5 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 2 mg/kg : Part 1 | 6 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 3 mg/kg: Part 1 | 3 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 4.5 mg/kg: Part 1 | 4 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 6.75 mg/kg: Part 1 | 8 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 10 mg/kg: Part 1 | 7 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 15 mg/kg: Part 1 | 6 | |
| Part 1: Dose Escalation Phase | NOT COMPLETED | PF-03446962 7 mg/kg: Part 2 | 0 | |
| Part 2: Exploratory Phase | STARTED | PF-03446962 0.5 mg/kg: Part 1 | 0 | |
| Part 2: Exploratory Phase | STARTED | PF-03446962 1 mg/kg: Part 1 | 0 | |
| Part 2: Exploratory Phase | STARTED | PF-03446962 2 mg/kg : Part 1 | 0 | |
| Part 2: Exploratory Phase | STARTED | PF-03446962 3 mg/kg: Part 1 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00557856/flow?page=2